Report Categories
View AllRecent Articles
View All
Jim Cramer Weighs In on ServiceNows Market Performance Amid AIDriven Demand
Prediction Markets Signal Rising Odds of Fed Rate Hike by July 2027
OpenAI Reportedly Poised for Confidential IPO Filing Signaling FirstMover Advantage in AI Sector
Dow Hits Record Close as AI Rally Pauses SP 500 Nasdaq Flat
Bond Market Signals Concern Over Feds Inflation Stance as Warsh Takes Helm
UK Exports to US Plunge 25 Following Trump Liberation Day Tariffs UK Now Faces Trade Deficit with Largest Partner
BIIB Q1 2026 Earnings Strong EPS Surprise Drives Stock Higher
PATH Q1 2026 Earnings EPS Surpasses Estimates by 155 Stock Advances
WHLRL Q2 2024 Earnings Unanticipated EPS Surge Amid Limited Disclosure
MMI Q1 2026 Earnings EPS Misses Estimates Amid Challenging Market
MOMO Q4 2025 Earnings EPS Misses Estimates Shares Edge Lower
Kodiak AI Inc Q1 2026 Earnings EPS Surges Past Estimates Stock Slips on Revenue Uncertainty
Yuanbao Inc YB Shares Tumble 974 Navigating Near Support Levels
AXIL Brands Inc AXIL Hovers Near Support Amid Modest Decline
RenaissanceRe Holdings RNR Shows Modest Decline Amid Stable Trading Support and Resistance Levels in Focus
Aimei Health Technology AFJKU Faces Sharp Decline Support Levels in Focus
Goosehead Insurance GSHD Retreats Over 6 as Shares Test Key Support Levels
External Links
Micron Technology Stock Surges on UBS Bullish Outlook and Strong Memory Chip Demand
uCloudlink Group UCL Q1 2026 Earnings NarrowerThanExpected Loss Fails to Propel Stock
Nuveen NASDAQ 100 Dynamic Overwrite Fund QQQX Hovers Near 31 as Market Consolidates
DRAM ETFs Record Growth Highlights Memory Chip Bottleneck in AI Buildout
Meta Tests AI Subscription Plans Starting at 799 Monthly
Oura Healths Smart Ring Emerges as a Leader in Wearable Health Monitoring
Retail Hiring Surges in April But Consumer Caution Flags Potential Slowdown
The Feds Path to Rate Cuts Narrows as CostofLiving Pressures Intensify
From Fragile Promise to Identity The Decade That Reshaped American Soccers Financial Landscape
Novartis Raises FullYear Sales and Profit Guidance Amid Strong Drug Performance